Zhejiang Launches Group Procurement for Five Categories of Medical Consumables
Johnson & Johnson
Medical Device R&D and Manufacturer
Reposting without authorization is prohibited; reposting is only permitted after 24 hours.
On June 18, provincial-level public medical institutions in Zhejiang Province officially releasedFlow-Diverter Stents, Hemodialyzers, Hemostatic Materials, Intradermal Needles (Press-Needles), Root Canal FilesAnnouncement on Group Procurement of Five Categories of Medical Consumables,Application Deadline:July 3, a new round of price cuts has officially begun.
The five product categories covered by this group procurement remainLed by Different Provincial Public Hospitals, the procurement cycle is uniformly set to2 years.
Flow Diverter StentAmong the 14 applicant companies, Covidien ranked first in procurement volume, followed byStryker, MicroPort NeuroTech;
HemodialyzerCategory, ShandongWEIGAOaccounting for 37% of the market share with 1,365,896 units;Nipro, Viat MedicalProducts Co., Ltd. ranked second and third, respectively.
Hemostatic MaterialsJohnson & JohnsonCovers multiple categories, including hemostatic gauze, non-woven fabric, fibrillar collagen, fluid gelatin, non-absorbable bone wax, and hemostatic granules;
Intradermal NeedleIn non-integrated categories,Nanjing DingshiLeading;
Root Canal FileJining DekaRanked first.
Group Purchasing by Large Tier-3A Hospitals
The Five Major Consumables Rules Vary
Although all are led by large tertiary hospitals to carry out consortium procurement,There are still significant differences in the selection rules.。
Flow-Diverter Stents, Hemodialyzers, Hemostatic Materials3Class adoptedVolume-Linked Coordination, products that have previously been selected in national provincial or inter-provincial alliance centralized procurement can be selected if their quoted price is no higher than the previous selection price and the national lowest price; products that have not been previously selected must refer to the median or highest price among the selected prices in the same group.
The entry barriers for such rules are relatively low, with the focus of competition lying in companies’ existing reserves of centralized procurement prices.
Intradermal Needlethen adoptBidding Rules, implement A/B grouping, rank by procurement demand volume, and assign the cumulative top 70% to Group A. Products in Group A qualify if they meet either of the following criteria: "not exceeding 1.8 times the lowest declared price" or "not exceeding 70% of the highest valid declared price." Products in Group B must also be priced no higher than the lowest price in Group A. The rules progress over three rounds, with Rule 3 allowingSecond-Round Quotation by Companies Not Selected in the First Round, a bid not exceeding the lowest selected price from the first round in the same group qualifies for shortlisting.
andThe rules for root canal files are the most complex, usingWeighted Quotation Calculation. The enterprise quotation is derived by weighting the product quotations against the procurement demand volume of medical institutions for each product within the same enterprise and group.Enterprises with a reduction of less than 15% in the first round of elimination, then eliminate bids from highest to lowest price until the elimination quota (80% of the number of validly declaring enterprises) is reached.
Enterprises with a price reduction of up to 25% will not be eliminated, but the allocation of agreed-upon volumes is directly linked to the reduction rate:
A 25% price reduction secures 65% of the self-assessed demand volume as the base volume, with a 25% adjustment out;
For every 1% increase in the price reduction, the base volume increases by 1%, and the delisted volume decreases by 1%;
A 50% price reduction qualifies for 90% of the base volume, with a phased-out volume of 0.
From the draft for public comment to the final official document, the selection criteria for root canal files have been changed from simple price ranking toVolume-Based Procurement with Tiered Base Allocation, aligning with the approach of national centralized procurement.
Since the provincial-level public medical institutions in Zhejiang Province launched group procurement in October 2025, it has been promoted in four batches, covering a cumulative number of varietiesExceeding 23 categories.
From the perspective of category evolution, group purchasing follows"Fill in the blank"Route.
The first batch focuses on commonly used consumables for endoscopy and general surgery; the second batch covers consumables for urology, oncology, interventional cardiology, and obstetrics/gynecology interventions; the third batch extends to neurointerventional procedures and long-term oncology care; while the fourth batch simultaneously targets high-value neurointerventional consumables, the hemodialysis market, hemostatic materials, traditional Chinese medicine acupuncture instruments, and dental nickel-titanium devices. The product categories range from high-value to low-value items, and from operating rooms to outpatient clinics.Boundaries continue to expand.
Zhejiang Provincial Medical Insurance Bureau explicitly proposed in the draft for comments on the "15th Five-Year Plan" that by 2030The number of medical consumable categories under centralized procurement has reached 60.and "encourage the establishment of a multi-party coordinated procurement mechanism, and launch pilot programs for group-based procurement of non-centrally procured items."
At the current pace of advancement, categories not yet fully covered by national centralized procurement or inter-provincial alliances, such asSutures, high-frequency surgical electrodes, in vitro diagnostic reagents, traditional Chinese medicine and rehabilitation consumables, ancillary consumables other than ophthalmic lenses, etc., all of which may become candidate directions for subsequent group procurement.
It should be noted that,The submission window for this application is only about ten days., with a tight schedule, relevant enterprises must complete the procedures as soon as possible. The announcement of the selected results for this group procurement is expected to be completed in mid-to-late July.
